XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Schedule of Amortized Cost and Estimated Fair Values of the Company’s Investments The amortized cost and estimated fair values of the Company’s investments as of September 30, 2022 were as follows:
   September 30, 2022 
       Unrealized   Unrealized     
   Amortized
Cost
   Holding
Gains
   Holding
Losses
   Fair
Value
 
Short-term:                
U.S. treasury and corporate notes  $2,981,010   $
   $2,870   $2,978,140 
Total  $2,981,010   $
   $2,870   $2,978,140 

 

Schedule of Computation of Diluted Net Loss Per Share The following potential common shares were not considered in the computation of diluted net loss per share as their effect would have been anti-dilutive for the three and nine months ended June 30, 2023 and 2022:
   2023   2022 
Warrants   6,407,495    6,753,444 
Stock options   1,708,906    1,245,582 
Restricted stock units   431,049    443,670